Chris Avery - Nemaura Medical Vice President - Global Business Operations

Mr. Chris Avery is Vice President Global Business Operations of the Company. Mr. Avery brings over 30 years of senior experience in the healthcare industry with a focus on launching products, establishing distribution channels, and developing international relationships. Previously, Mr. Avery cofounded DiagnoSys Medical, a UK medical device distribution company. In this role, Mr. Avery recruited, trained, and launched a fieldbased sales team and was responsible for negotiating the sale of the business to Home Diagnostics. Subsequently, Mr. Avery served as European Director and UK Managing Director at Home Diagnostic Inc. During his tenure at Home Diagnostics, Mr. Avery launched the company glucose monitoring portfolio, Orbus Stents and Animas insulin pumps, into the UK and helped build the European distribution network. Following Home Diagnostics Inc., Mr. Avery served as European Director and UK Managing Director at Nipro Diagnostics, a company dedicated to helping people with diabetes manage their disease by providing blood glucose monitoring systems and other diabetes products. While at Nipro, he refocused the organization, delivering a new strategic direction and leadership that increased market penetration. Additionally, Mr. Avery established and managed the sales operations for the organization within various regions and oversaw distributors within the EU and Africa. Most recently, Mr. Avery served as Senior Vice President of Business Development at Dallas Burston Ethitronix, where he was heavily involved in establishing and overseeing the Collaboration Agreement with Nemaura to commercialize SugarBEAT in Europe. Mr. Avery oversaw the prelaunch phase for the distribution of SugarBEAT, cultivating relationships with suppliers and diabetes key opinion leaders. since 2019.